Investigational drug · Phase 2
AT-004
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Acne Vulgaris on the Face.
Phase 2Last checked: Nov 19, 2026Latest source record: Aug 19, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
0 still active
All registered trials
1
Any phase or sponsor naming "AT-004"
First trial start
2026
Feb 2, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "AT-004", any sponsor or status.
Conditions studied
As listed on its trial records.
- Acne Vulgaris on the Face
Approved drugs for the same conditions: Acne · Dermatology
Largest trials
Live from ClinicalTrials.gov: studies naming "AT-004" as an intervention, largest first.
Arctic TherapeuticsIndustry
NCT07774364 · 63 participants · Start Feb 2, 2026 · Primary completion Jul 15, 2026
Drug: AT-004; Placebo · For: Acne Vulgaris on the Face
Sites: Gandrup, Denmark; Herlev, Denmark; Vejle, Denmark
Newest research
PubMed records naming it or its code names, newest first.
- Evaluating phytoextraction efficiency of two high-biomass crops after soil amendment and inoculation with rhizobacterial strains.
Vanessa ÁL, Ángeles PF, Sergio R, et al. · Environ Sci Pollut Res Int 2017
- In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations.
Ferrari F, Cerlesi MC, Malfacini D, et al. · Eur J Pharmacol 2016
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.